Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 5, 2014, Pages

  Cuppoletti, John ^a   Chakrabarti, Jayati ^a   Tewari, Kirti P ^a   Malinowska, Danuta H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CFTR inhibitor 172; DASU 02; Forskolin; Lubiprostone; Methadone

Indexed keywords

CHLORIDE CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPSTEIN BARR VIRUS ANTIGEN 1; FORSKOLIN; HUMAN CLC 2 CHLORIDE CHANNEL; HUMAN RECOMBINANT CLC 2 CHLORIDE CHANNEL; ISOBUTYLMETHYLXANTHINE; ISONIAZID; LUBIPROSTONE; METHADONE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CHLORIDE TRANSPORT; CONSTIPATION; CONTROLLED STUDY; DIFFERENTIATION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IRRITABLE COLON; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PHARMACEUTICAL CARE; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP;

CFTR INHIBITOR 172; DASU-02; FORSKOLIN; LUBIPROSTONE; METHADONE;

1-METHYL-3-ISOBUTYLXANTHINE; CELL LINE; CHLORIDE CHANNELS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; METHADONE; UREA;

EID: 84907357162     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00077.2014     Document Type: Article

References (50)

1. Anderson MP, Welsh MJ. Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci USA 88: 6003-6007, 1991.
2. - secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84. Dig Dis Sci 56: 339-351, 2011.
3. Bao HF, Liu L, Self J, Duke BJ, Ueno R, Eaton DC. A synthetic prostone activates apical chloride channels in A6 epithelial cells. Am J Physiol Gastrointest Liver Physiol 295: G234-G251, 2008.
4. - secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology 137: 976-985, 2009.
5. Cheng G, Kim MJ, Jia G, Agrawal DK. Involvement of chloride channels in IGF-I-induced proliferation of porcine arterial smooth muscle cells. Cardiovasc Res 73: 198-207, 2007.
6. Cid LP, Montrose-Rafizadeh C, Smith DI, Guggino WB, Cutting GR. Cloning of a putative human voltage-gated chloride channel (CIC-2) cDNA widely expressed in human tissues. Hum Mol Genet 4: 407-413, 1995.
7. - currents. Cell Biochem Biophys 66: 53-63, 2013.
8. Cuppoletti J, Malinowska DH, Tewari KP, Li QJ, Sherry AM, Patchen ML, Ueno R. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol 287: C1173-C1183, 2004.
9. Cuppoletti J, Malinowska DH, Chakrabarti J, Tewari KP, Ueno R. Amino acids involved in lubiprostone activation of human ClC-2. FASEB J 28: 896.11, 2014.
10. - channel. J Biol Chem 279: 21849-21856, 2004.
11. Dalton GD, Dewey WL. Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides 40: 23-34, 2006.
12. + channel. Am J Physiol Lung Cell Mol Physiol 271: L775-L784, 1996.
13. Devor D, Singh AK, Lambert LC, DeLuca A, Frizzell RA, Bridges RJ. Bicarbonate and chloride secretion in calu-3 human airway epithelial cells. J Gen Physiol 113: 743-760, 1999.
14. Duan DD. Phenomics of cardiac chloride channels. Compr Physiol 3: 667-692, 2013.
15. Fischer H, Illek B, Machen TE. Regulation of CFTR by protein phosphatase 2B and protein kinase C. Pflügers Arch 436: 175-181, 1998.
16. Gadsby DC, Nairn AC. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 79: S77-S107, 1999.
17. Glass DB, Cheng HC, Mende-Mueller L, Reed J, Walsh DA. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264: 8802-8810, 1989.
18. Guo Y, Su M, McNutt MA, Gu J. Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain. J Histochem Cytochem 57: 1113-1120, 2009.
19. Joo NS, Clarke LL, Han BH, Forte LR, Kim HD. Cloning of ClC-2 chloride channel from murine duodenum and its presence in CFTR knockout mice. Biochim Biophys Acta 1446: 431-437, 1999.
20. inh172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition. J Pharmacol Exp Ther 333: 60-69, 2010.
21. Kyoung Son Y, Sun Park W, Kim SJ, Earm YE, Kim N, Boum Youm J, Warda M, Kim E, Han J. Direct inhibition of a PKA inhibitor, H-89 on KV channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun 341: 931-937, 2006.
22. LeSimple P, Liao J, Robert R, Gruenert DC, Hanrahan JW. Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. J Physiol 588.8: 1195-1209, 2010.
23. Lipecka J, Bali M, Thomas A, Fanen P, Edelman A, Fritsch J. Distribution of ClC-2 chloride channel in rat and human epithelial tissues. Am J Physiol Cell Physiol 282: C805-C816, 2002.
24. Lochner A, Moolman JA. The many faces of H89: a review. Cardiovasc Drug Rev 24: 261-274, 2006.
25. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
26. + channel (ENaC) in fetal rat alveolar type II epithelium. Biochem Pharmacol 66: 1083-1089, 2003.
27. Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. Am J Physiol Gastrointest Liver Physiol 292: G647-G656, 2007.
28. Nighot PK, Blikslager AT. ClC-2 regulates mucosal barrier function associated with structural changes to the villus and epithelial tight junction. Am J Physiol Gastrointest Liver Physiol 299: G449-G556, 2010.
29. Nighot PK, Blikslager AT. Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol 302: C178-C187, 2012.
30. Nighot PK, Moeser AJ, Ryan KA, Ghashghaei T, Blikslager AT. ClC-2 is required for rapid restoration of epithelial tight junctions in ischemic-injured murine jejunum. Exp Cell Res 315: 110-118, 2009.
31. O'Donnell EK, Sedlacek RL, Singh AK, Schultz BD. Inhibition of enterotoxin-induced porcine colonic secretion by diarylsulfonylureas in vitro. Am J Physiol Gastrointest Liver Physiol 279: G1104-G1112, 2000.
32. - channel but does not change activity. J Membr Biol 182: 31-37, 2001.
33. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 292: L383-L395, 2007.
34. Plog S, Mundhenk L, Bothe MK, Klymiuk N, Gruber AD. Tissue and cellular expression patterns of porcine CFTR: similarities to and differences from human CFTR. J Histochem Cytochem 58: 785-797, 2010.
35. Ratté S, Prescott SA. ClC-2 channels regulate neuronal excitability, not intracellular chloride levels. J Neurosci 31: 15838-15843, 2011.
36. - transport of mouse aortic smooth muscle cells. J Physiol 568.2: 483-495, 2005.
37. Schiffhauer ES, Vij N, Kovbasnjuk O, Kang PW, Walker D, Lee S, Zeitlin PL. Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia. Am J Physiol Lung Cell Mol Physiol 304: L324-L331, 2013.
38. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79: S145-S166, 1999.
39. Singh AK, Schultz BD, van Driessche W, Bridges RJ. Transepithelial fluctuation analysis of chloride secretion. J Cystic Fibrosis 3: 127-132, 2004.
40. inh172, glibenclamide and GlyH-101. Am J Physiol Cell Physiol 302: C67-C76, 2012.
41. ir channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun 340: 1104-1110, 2006.
42. + current by H-89 in rabbit coronary arterial smooth muscle cells. Vasc Pharmacol 46: 105-113, 2007.
43. Takuma T, Ichida T. Evidence for the involvement of protein phosphorylation in cyclic AMP-mediated amylase exocytosis from parotid acinar cells. FEBS Lett 340: 29-33, 1994.
44. Tewari KP, Malinowska DH, Sherry AM, Cuppoletti J. PKA and arachidonic acid activation of human recombinant ClC-2 chloride channels. Am J Physiol Cell Physiol 279: C40-C50, 2000.
45. Thiagarajah JR, Broadbent T, Hsieh E, Verkman AS. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126: 511-519, 2004.
46. Thiemann A, Gründer S, Pusch M, Jentsch TJ. A chloride channel widely expressed in epithelial and non-epithelial cells. Nature 356: 57-60, 1992.
47. Thompson CH, Olivetti PR, Fuller MD, Freeman CS, McMaster D, French RJ, Pohl J, Kubanek J, McCarty NA. Isolation and characterization of a high affinity peptide inhibitor of ClC-2 chloride channels. J Biol Chem 284: 26051-26062, 2009.
48. Vandebrouck C, Melin P, Norez C, Robert R, Guibert C, Mettey Y, Becq F. Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Respir Res 7: 113-122, 2006.
49. Veilleuxa S, Holt N, Schultz B, Dubreuil JD. Escherichia coli EAST1 toxin toxicity of variants 17-2 and O42. Comp Immunol Microbiol Infect Dis 31: 567-578, 2008.
50. Wang XF, Reddy MM, Quinton PM. Effects of a new cystic fibrosis conductance regulator inhibitor on human sweat ducts. Exp Physiol 89.4: 417-425, 2004.